Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis.
- DOI
- 10.1016/j.biopha.2026.119490
- Published
- 2026 Jun
- Container
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119490,
title = {Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis.},
author = {Navarrete-Carriola DV and Chan-Bacab MJ and De Angelis L and Quintero-Solano JM and Sánchez-Palestino LM and Ortiz-Pérez E and Bautista-Hernández MA and Moreno-Rodríguez A and Mendoza-Conde M and Vázquez C and Saavedra E and Doyle MP and Rivera G},
year = {2026},
journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
doi = {10.1016/j.biopha.2026.119490},
url = {https://doi.org/10.1016/j.biopha.2026.119490}
}RIS
TY - JOUR TI - Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis. AU - Navarrete-Carriola DV AU - Chan-Bacab MJ AU - De Angelis L AU - Quintero-Solano JM AU - Sánchez-Palestino LM AU - Ortiz-Pérez E AU - Bautista-Hernández MA AU - Moreno-Rodríguez A AU - Mendoza-Conde M AU - Vázquez C AU - Saavedra E AU - Doyle MP AU - Rivera G PY - 2026 JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie DO - 10.1016/j.biopha.2026.119490 UR - https://doi.org/10.1016/j.biopha.2026.119490 ER -
APA
DV, N., MJ, C., L, D. A., JM, Q., LM, S., E, O., MA, B., A, M., M, M., C, V., E, S., MP, D., & G, R. (2026). Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119490
Source records
- pubmed · retrieved 2026-09-27T16:30:11.676Z
- europe-pmc · retrieved 2026-09-27T16:30:11.680Z